-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUTEP ANNOUNCES POSITIVE UPDATE ON IMP761, A FIRST-IN-CLASS LAG-3 AGONIST ANTIBODY FOR AUTOIMMUNE DISEASES, FROM PHASE I STUDY

路透·12/22/2025 13:00:03

登录查看新闻详情